We have previously shown that the extracellular matrix molecule tenascin-C inhibits fibronectin-mediated cell adhesion and neurite outgrowth by an interaction with a cellular RGDindependent receptor which interferes with the adhesion and neurite outgrowth promoting activities of the fibronectin receptor(s). Here we demonstrate that the inhibitory effect of tenascin-C on β 1 integrin-dependent cell adhesion and neurite outgrowth is mediated by the interaction of the protein with membrane-associated disialogangliosides, which interferes with protein kinase C-related signaling pathways. First, in substratum mixtures with fibronectin, an RGD sequencecontaining fragment of the molecule or synthetic peptide, tenascin-C inhibited cell adhesion and spreading by a disialoganglioside-dependent, sialidase-sensitive mechanism leading to an inhibition of protein kinase C. Second, the interaction of intact or trypsinized, i.e., cell surface glycoproteinfree, cells with immobilized tenascin-C was strongly inhibited by gangliosides or antibodies to gangliosides and tenascin-C. Third, preincubation of immobilized tenascin-C with soluble disialogangliosides resulted in a delayed cell detachment as a function of time. Similar to tenascin-C, immobilized antibody to GD2 (3F8) or sphingosine, a protein kinase C inhibitor, strongly inhibited RGD-dependent cell spreading. Finally, the degree of tenascin-C-induced inhibition of cell adhesion was proportional to the degree of disialoganglioside levels of expression by different cells suggesting the relevance of such mechanism in modulating integrin-mediated cell-matrix interactions during pattern formation or tumor progression.
Introduction
Cellular interactions with the extracellular matrix (ECM) govern such fundamental processes as cell migration and differentiation and axonal guidance during development, regeneration and oncogenesis (reviewed by Adams and Watt, 1993; Juliano and Varner, 1993; Gumbiner, 1996) . Fibronectin (FN) is one of the adhesive glycoproteins of the ECM which promotes cell adhesion and neurite outgrowth, processes mediated mainly by two types of cellular receptors including integrins (RGD-dependent) and cell surface proteoglycans (RGD-independent; reviewed by Reichardt and Tomaselli, 1991; Schwartz et al., 1995) . Integrin-mediated adhesion of cells to ECM proteins is a complex multistep process characterized by initial recognition and signal transduction, leading to reorganization of the cytoskeleton at the site of interaction with the ECM, and stabilization of focal contacts produced by the clustering of membrane receptors and cytoskeletal elements (reviewed by Yamada and Miyamoto, 1995) . Therefore, factors which can modulate the activity or ligand binding specificity of integrins by extra-(outside-in) or intracellularly (inside-out) induced mechanisms are of vital importance for the correct tissue assembly during morphogenesis. As previously shown, tenascin-C (TN-C), an ECM component with anti-adhesive properties, interferes with FN-mediated adhesion by causing detachment of cells and inhibition of neurite outgrowth (Chiquet-Ehrismann et al., 1988; Probstmeier et al., 1990a; Pesheva et al., 1994; reviewed by Chiquet-Ehrismann, 1995; Faissner et al., 1996) . TN-C is a multidomain glycoprotein built up by EGF-and FN type III-like structural motifs and a C-terminal region homologous to fibrinogen. Together with tenascin-R (TN-R; Nörenberg et al., 1992; Fuss et al., 1993) , tenascin-X (TN-X; Bristow et al., 1993) and the recently identified tenascin-Y (Hagios et al., 1996) , it has been defined as a member of the TN multigene family (reviewed by Erickson, 1993; Chiquet-Ehrismann, 1995) .
TN-C is expressed in a temporally and spatially restricted manner during early morphogenesis by astrocytes in the central (CNS) and Schwann cells in the peripheral nervous system (PNS), as well as by a number of cells of mesodermal origin outside the nervous system (reviewed by Edelman and Jones, 1992; Riou et al., 1992; Venstrom and Reichardt, 1993; Faissner et al., 1996) . It is noteworthy that a particular morphogenetic process often correlates with the expression of different TN-C isoforms possibly reflecting distinct functional properties (see, for example, Jones et al., 1989; Prieto et al., 1990; Chiquet-Ehrismann et al., 1991; Kaplony et al., 1991; Tucker, 1993) . With progressing structural and functional differentiation, TN-C expression becomes downregulated. A characteristic event following trauma or neoplastic transformation is often the upregulation of TN-C expression thus implying the modulatory role of this anti-adhesive molecule in regenerative processes and oncogenesis (reviewed by Chiquet-Ehrismann, 1993; ChiquetEhrismann et al., 1995) . With respect to integrin-mediated cell adhesion and process formation, the possibility for such mode of action is strengthened by the observations that TN-C inhibits neurite outgrowth and the adhesion of a variety of cell types on FN substrata by mechanisms based on its interaction with (1) FN (TN-C 190 isoform) leading to a modulation of the substratum properties of FN Pesheva et al., 1994; Chung et al., 1995; Fischer et al., 1997) , (2) different integrins Prieto et al., 1993; Schnapp et al., 1995; Yokosaki et al., 1996) , or (3) cellular, RGD-independent receptors affecting the function of β 1 integrins (Pesheva et al., 1994; Chung et al., 1996) . Studies of several groups have (upper panel) and spreading (lower panel) on mixed substrata. The number of cells adherent/spread on BSA + FN substrata preincubated without additives was set as 100%. In (A) and (B), TN-C substrata were preincubated in the absence or presence of polar glycolipids (all at 2 µg/ml in 1% BSA in PBS) for 60 min at 37_C and cell attachment and spreading were evaluated after 60 min of culture. (C) Effect of sialidase treatment on L cell adhesion to mixed FN substrata. L cells (1 × 10 6 cells/ml medium) treated without (-S) or with sialidase (+ S) were plated onto BSA + FN or TN-C + FN substrata and cell attachment was measured after 30 min of incubation at 37_C. The number of cells adherent to BSA + FN substrata was set as 100%. Values represent the means ± SD of two independent experiments performed in triplicates (for B and C).
demonstrated that membrane-associated glycosphingolipids, such as mono-(GM3) and disialogangliosides (GD2 and GD3) may serve as enhancers or modulators of integrin-mediated adhesion of cells to FN (Cheresh et al., 1986 (Cheresh et al., , 1987 Burns et al., 1988; Stallcup et al., 1989; Kojima and Hakomori, 1991) . Notably, TN-C expression often coincides, temporally and spatially, with that of FN and the ganglioside-integrin cell recognition system under normal and pathological conditions (see above).
In the present study, we describe a novel mechanism of inhibition of RGD-dependent cell adhesion to FN by TN-C induced by its interaction with membrane-associated disialogangliosides, such as GD2 and GD3. This interaction at the cell surface results in a modulation of β 1 integrin action as suggested by the disialoganglioside-sensitive inhibition of cell adhesion and process formation on RGD sequence-containing FN fragments or peptides by substratum-bound TN-C. The described TN-C-mediated inhibitory mechanism affects protein kinase C (PKC)-related signaling pathways most likely by induction of glycosphingolipid turnover.
Results

Disialogangliosides are involved in the inhibitory action of TN-C in FN-mediated cell adhesion and neurite outgrowth
The lipid composition of the cell membrane might be critical for the functional activity of some integrins (Conforti et al., 1990; Hermanowski-Vosatka et al., 1992) . In particular, gangliosides have synergistic effect on integrin-mediated adhesion of cells to FN (Burns et al., 1988; Stallcup et al., 1989; Kojima and Hakomori, 1991) . As TN-C inhibits FN-mediated cell adhesion and neurite outgrowth via its interaction with a putative cellular receptor different from the α 5 β 1 integrin (Pesheva et al., 1994) , we were further interested in the question whether gangliosides may represent this putative cellular receptor mediating the inhibition of RGD-dependent cell adhesion to FN.
We first studied the effect of different gangliosides on the adhesion and spreading of L 929 cells on mixed TN-C + FN substrata in short-term adhesion assays ( Figure 1 ). As previously Freshly dissociated neurons were plated at low density (3 × 10 5 cells/ml) allowing the examination of neurites from single cells and maintained on the different substrata for 24 h without glycolipid (-GL; a-b) or in the presence of GD2 (c-d) and GM1 (e-f). Cultures were then treated with 4% PA in PBS containing 5% sucrose for 20 min and subsequently stained with toluidine blue in 4% PA to visualize all neurites and cell bodies. Red blood cells (a, b, arrows) were occasionally present in the cultures. Note the well-developed growth cones of neurites (d, arrowheads) growing on TN-C + FN substrata in the presence of GD2 and the lack of neurite outgrowth on these substrata in the absence of the glycolipid (b). Scale bar, 100 µm. (B) Quantitative data on the effect of glycosphingolipids on the neurite outgrowth from dorsal root ganglion neurons. Cultures were treated as described under (A) and the number of cells with neurites longer than 10 µm on BSA + FN substrata in the absence of glycolipids was set as 100%. Mean values ± SD of two independent experiments performed in triplicates are shown.
shown (Pesheva et al., 1994) , these substrata reduced cell adhesion and spreading as compared to control BSA + FN substrata ( Figure 1A , a-b). After preincubation of these substrata with disialogangliosides, such as GD2 or GD3, the inhibitory properties of TN-C + FN were almost neutralized, while no change in the number of cells adhering to BSA + FN substrata was observed ( Figure 1A , c-d, for GD2; see also Figure 1B ). Moreover, the number of cells which spread on TN-C + FN substrata after 60 min of culture was comparable to that on BSA + FN substrata (Figure 1A, and 1B) . Sulfatides or mono-and trisialogangliosides did not affect the inhibitory properties of TN-C ( Figure 1A , e-f, and 1B). The effect of disialogangliosides was related only to FN-mediated adhesion of L cells since the adhesive properties of mixed laminin (LN) substrata were not influenced by the presence of glycolipids (not shown). Similar results were obtained for the adhesion of neural tumor cell lines (A 172 and N2A) to mixed FN substrata (see Figure 6B ).
If cell surface sialogangliosides are involved in the inhibitory action of TN-C, the latter should then be prevented upon removal of cell surface-associated sialic acid. Treatment of L cells with sialidase resulted in a drastic increase in the number of adherent cells (up to 80% of the control values on BSA + FN substrata) as compared to the reduced attachment of cells pretreated without enzyme ( Figure 1C ). Sialidase-treated L cells did not, however, spread on TN-C + FN substrata as this was the case in the presence of disialogangliosides.
When dorsal root ganglion neurons were tested for adhesion and neurite outgrowth on mixed substrata, the inhibitory properties of TN-C for neurite outgrowth were completely neutralized in the presence of disialogangliosides, but not by other glycolipids (Figure 2A,B) . After 24 h of culture, neurites with well developed growth cones comparable to those present on FN substrata lacking TN-C were observed (Figure 2A, c-d) .
TN-C inhibits RGD-/β 1 integrin-dependent cell adhesion to FN by a disialoganglioside-mediated mechanism
The results presented above strongly suggest that TN-C inhibits FN-mediated cell adhesion by an interaction with membrane-associated gangliosides. Such interaction at the cell surface may further influence the function/activity of the RGD-dependent FN receptor (β 1 integrin). To examine this possibility, we studied the adhesion of L cells to mixed substrata consisting of TN-C and the 33/66 kDa heparin binding or 75 kDa cell binding FN fragment in the absence and presence of different gangliosides (Figure 3 , for GD2). After 1 h of culture, mixed substrata containing BSA and the 33/66 kDa heparin binding fragment of FN (BSA + 33/66 kD) supported the attachment of L cells in a disialogangliosideindependent manner, while TN-C + 33/66 kDa substrata were always inhibitory independently of the presence or absence of different gangliosides (for GD2, see Figure 3 ). The number of cells which remained attached on TN-C + 75 kDa substrata was drastically reduced (to about 20%) as compared to that on control BSA + 75 kDa substrata. After preincubation of the substrata with GD2, this inhibition was strongly reduced. The same neutralizing effect displayed GD3 and, to a lower extent, GD1a while monoand trisialogangliosides did not interfere with the inhibition of cell adhesion to the 75 kDa FN fragment by TN-C (not shown). Furthermore, TN-C inhibited cell adhesion to substratum mixtures with RGD sequence-containing peptide conjugated to ovalbumin and this inhibition was almost completely neutralized in the presence of disialogangliosides (Figure 3) . Fig. 3 . Effect of GD2 on L cell adhesion to mixed 33/66 kDa FN fragment, 75 kDa FN fragment and RGD sequence-containing substrata. Mixed substrata consisting of BSA or TN-C + 33/66 or 75 kDa fragment, and ovalbumin (OVA) or TN-C + GRGDS cell binding peptide conjugated to OVA (RGD) were prepared as described (Pesheva et al., 1994) . The adhesion of L cells (1 × 10 6 cells/ml medium) to these substrata in the absence of glycolipid (-GL) and presence of GD2 (+ GD2) was evaluated after 60 min of culture. The number of cells attached to BSA + 33/66 kDa, BSA + 75 kDa, and OVA + RGD in the absence of glycolipid was set as 100%. Values represent the means ± SD of two independent experiments performed in triplicates.
These results suggest that TN-C (1) inhibits the RGD-dependent cell adhesion to FN by an interaction with cell surface disialogangliosides and (2) affects the interaction of cell surface proteoglycans with the heparin binding fragment of FN in a disialoganglioside-independent manner.
Disialogangliosides are cellular receptors for TN-C
To determine whether cell surface exposed glycosphingolipids could serve as receptor(s) for TN-C, we next examined the interaction of L cells treated in different ways with TN-C immobilized alone as a substratum. As previously shown, glutaraldehyde-treated L (GA-L) cells stably attached to immobilized TN-C due to inactivation of intracellular response mechanisms leading to cell detachment ( Figure 4A , left panel; Pesheva et al., 1994) . After preincubation of TN-C substrata with different polar glycolipids, the attachment of these cells was inhibited by about 50% by gangliosides while sulfatides, which have been shown to serve as ligands for TN-C (Crossin and Edelman, 1992) , did not interfere with cell attachment. To analyze the type of ganglioside involved in the interaction of GA-L cells with TN-C, cell adhesion assays were carried out using mono-, di-, and trisialogangliosides as competitors ( Figure 4A ). Disialogangliosides, such as GD2, GD3, and, to a lower extent, GD1a, inhibited attachment of L cells to TN-C by ∼60% (shown for GD2), while mono-and trisialogangliosides had no effect. Furthermore, in the presence of 3F8 antibody to GD2 in the incubation medium, cell attachment to TN-C was inhibited to the same extent as by soluble GD2. The number of GA-L cells attached to TN-C substrata was strongly reduced in the presence of polyclonal TN-C (pTN-C) antibodies, while monoclonal antibodies J1/tn3, 4, and 5 recognizing different protein epitopes on the TN-C molecule (Husmann et al., 1992; Götz et al., 1996) did not interfere with attachment (shown for J1/tn3). Notably, monoclonal antibody J1/tn2 to TN-C, which has been shown to interfere with the neurite outgrowth-promoting effect of TN-C on hippocampal neurons (Lochter et al., 1991) , reduced GA-L cell attachment to a similar extent as GD2 ( Figure 4A ). Similar data were obtained for the short-term adhesion (10 min) of live L (not shown) and N2A cells to substratum-bound TN-C ( Figure 4B ). The initial interaction of N2A cells, which strongly express both GD2 and GD3 (see Figure 6A ), with TN-C was also inhibitable (by about 60-70%) by disialogangliosides (shown for GD2), 3F8 and J1/tn2 antibodies, as well as by soluble TN-C ( Figure 4B ).
If membrane surface glycosphingolipids are receptors for TN-C, cells depleted in cell surface exposed glycoproteins should also be able to attach to TN-C substrata. To remove cell surface glycoproteins, cells were extensively trypsinized, treated subsequently with glutaraldehyde and then used for cell-substratum adhesion assays ( Figure 4A , right panel). Trypsinized, glutaraldehyde treated L (TGA-L) cells attached to TN-C, but not to FN or the 75 and 33/66 kDa FN fragments (not shown). In analogy to GA-L cells, the attachment of TGA-L cells to TN-C substrata was almost completely abolished by gangliosides, disialogangliosides, and antibodies to GD2 (+ 3F8) and TN-C (+ J1/tn2, pTN-C).
As previously shown, TN-C is capable of inducing hemagglutination of red blood cells (RBC) by a mechanism probably involving its interaction with glycolipids exposed at the cell surface of RBC (Chiquet-Ehrismann et al., 1988) . We were further interested in the question whether cell surface glycolipids on RBC are also capable of mediating the attachment of these cells to substratum-bound TN-C ( Figure 4C ). Trypsinized, GA-treated RBC (TGA-RBC) stably attached to TN-C substrata, and their attachment was selectively inhibited by RBC-derived fraction of polar glycolipids, gangliosides, and disialogangliosides (shown for GD2). Preincubation of TN-C substrata with sulfatides or gangliosides containing less (GM1) or more (GT1b) than two sialic acids did not affect TGA-RBC attachment to TN-C. Monoclonal antibody J1/tn2 completely abolished cell attachment, while antibodies J1/tn3 and J1/tn4 did not interfere with TN-C-RBC interaction. Notably, antibodies to GD2 (3F8) and gangliosides (A2B5), but not to sulfatides (O4) which are also expressed at the cell surface of RBC (Hansson et al., 1978 ; not shown), reduced TGA-RBC attachment by about 50% ( Figure  4C ).
Thus, gangliosides could serve as cellular receptors for TN-C and different cell types can use glycosphingolipids of this group in their interaction with the ECM.
Interaction of TN-C with cell surface disialogangliosides is coupled to a signal transduction leading to cell detachment
To clarify whether the interaction of TN-C with cell surface disialogangliosides induces a signaling cascade resulting in the rapid cell detachment observed, we next addressed the following questions.
(1) Is ligand interaction with cell surface disialogangliosides the reason for cell detachment; (2) What could be the basis of such glycosphingolipid-mediated, β 1 integrin-dependent signaling mechanism; and (3) Does the level of cell surface expression of disialogangliosides correlate with the degree of TN-C-mediated inhibition of β 1 integrin-dependent cell adhesion, i.e., is such mechanism biologically relevant to the modulation of cell behavior?
To address the first question, we examined the kinetics of L cell adhesion to TN-C substrata in the absence or presence of gangliosides ( Figure 5A ). After 5-10 min of culture, a maximal number of cells (about 100% of the input) attached to TN-C substrata in the absence of glycolipids. The initial cell attachment were plated onto TN-C substrata preincubated in the absence (-GL) or presence of polar glycolipid fraction from RBC (+ RBC GL, 20 µg/ml), sulfatides (+ sulf.), ganglioside mixture (+ gang., 20 µg/ml), mono-(+ GM1), di-(+ GD2), and trisialogangliosides (+ GT1b; all at 2 µg/ml) for 60 min at 37_C. In antibody perturbation experiments, TN-C substrata were preincubated with monoclonal (+ J1/tn2, J1/tn3, or J1/tn4) and polyclonal (+ pTN-C) antibodies to TN-C (200 µg/ml) for 60 min at 37_C. Antibodies to gangliosides (+ 3F8, 100 µg/ml; + A2B5, concentrated culture medium) or soluble TN-C (10 µg/ml) were added to the cells prior to their plating onto the substrata. Unbound glycolipids and antibodies were washed away and cell suspensions in 1% BSA in PBS (L cells and RBC) or incubation medium (N2A cells) were incubated with the substrata for 10 (N2A cells) or 60 min (L cells and RBC) at 37_C. Attachment of cells to TN-C in the absence of glycolipids was set as 100%. Values represent the means ± SD of two (N2A cells) to four (L cells and RBC) independent experiments performed in triplicates.
was followed by a drastic reduction (down to 40% of the initially bound cells) in the number of adherent cells already after 20 min of culture and after 30 min, this number further dropped to less than 20% of the initially attached cells. Preincubation of TN-C substrata with disialogangliosides (GD2 or GD3) resulted in an inhibition (of about 50%) of L cell attachment at initial time points of interaction (after 5 min) with the substratum and reduced cell detachment from TN-C after 20 and 30 min (about 40% more adherent cells than in the absence of disialogangliosides) of culture ( Figure 5A , for GD2). Disialogangliosides did not interfere with L cell adhesion to FN or LN substrata (not shown). Hence, ligand (i.e., TN-C) interaction with membrane-associated disialogangliosides is likely to activate a signaling cascade leading to impaired cell spreading and finally to cell detachment. Supporting this possibility is our finding that 3F8 antibody to GD2 exhibited the same inhibitory effect on FN-mediated adhesion of L cells as TN-C, thus mimicking the action of a natural ligand for disialogangliosides ( Figure 5B ). When immobilized as a substratum, 3F8 IgG supported the initial attachment of L cells (after 10 min), but did not support cell adhesion after 60 min of culture (not shown). In a mixture with adhesive ECM molecules (LN or FN), the antibody selectively interfered with the β 1 integrin-dependent cell adhesion to FN. Whereas nonimmune IgG or polyclonal IgG to NCAM (the latter reacting with NCAM on L cells) did not affect L cell adhesion to FN mixed substrata, 3F8 IgG inhibited cell spreading on FN (by 30%) and, to a greater extent, on the 75 kDa (by 80%), but not on the 33/66 kDa FN fragment ( Figure 5B ). 3F8 IgG had a minimal effect on the attachment of cells to FN and 75 kDa fragment, suggesting that a β 1 integrin-coupled signaling cascade, rather than the interaction of this integrin with its ligand, has been affected by the antibody. Under the same assay conditions, 3F8 IgG did not interfere with LN-mediated adhesion of L cells (not shown).
The inhibition of focal adhesion and cell spreading by TN-C and GD2-specific antibody suggested to us that the interaction with cell surface disialogangliosides may affect the action of the RGD-dependent integrin by inhibition of PKC: (1) ligand binding to glycosphingolipids, in general, may lead to sphingolipid turnover resulting in inhibition of PKC activity (Hannun and Bell, 1989) , and (2) PKC activity, in particular, can be strongly inhibited by disialogangliosides (Kreutter et al., 1987) . Interaction of TN-C with cell surface disialogangliosides can thus induce their degradation to sphingosine which inhibits the activity of PKC (Hannun et al., 1986) . To test whether such signal transduction mechanism can be triggered by TN-C, we next examined the adhesion of L cells to FN fragments in the presence of increasing amounts of sphingosine ( Figure 5C ). After 60 min of culture, the number of cells adhering to the 33/66 kDa FN fragment was not substantially affected by the presence of sphingosine (up to 30 µM). By contrast, this glycolipid derivative strongly inhibited cell adhesion/spreading to the 75 kDa fragment (see Figure 5C ). Since L cells interact with the 75 kDa FN fragment in a RGD-/β 1 integrin-dependent manner (Pesheva et al., 1994) , sphingosine most likely interferes with the activity of the cellular α 5 β 1 integrin by inhibition of PKC. Finally, we examined the activity of PKC in cells cultured on mixed TN-C + FN substrata and compared it to that in cells on control BSA + FN substrata ( Figure 5D ). L cells were plated into culture dishes coated with mixed FN substrata and after 60 min of culture, PKC Increasing amounts of sphingosine in 100% ethanol (at a final concentration of 0-30 µM) or ethanol only were added to single cell suspensions (1 × 10 6 cells/ml in DMEM containing 10% FCS) which were immediately plated onto 33/66 or 75 kDa substrata (both coated at a concentration of 40 µg/ml) and cell adhesion was evaluated after 60 min of culture. The number of cells adherent to each FN fragment in the absence of sphingosine was set as 100% and the number of cells adhering to the corresponding fragment in the presence of sphingosine was related to this value and expressed as percent inhibition of cell adhesion. Values represent the means ± SD of two independent experiments performed in triplicates. (D) Effect of TN-C on PKC activity in L cells maintained on FN mixed substrata. L cells (5 × 10 6 cells/dish) were cultured for 60 min on mixed FN substrata containing BSA (BSA + FN) or TN-C (TN-C + FN) and PKC activity in the cytosolic fractions isolated from these cells was detected by using a nonradioactive protein kinase assay kit (Calbiochem). After 60 min of incubation with the pseudosubstrate, the values for the PKC activity in each fraction were plotted onto a standard curve prepared from serial dilutions of rat brain-derived PKC assayed in parallel. Values for the PKC activity in L cells maintained on BSA + FN substrata were set as 100%. Mean values ± SD of two independent experiments performed in triplicates are shown. Downloaded from https://academic.oup.com/glycob/article-abstract/9/2/101/615469 by guest on 11 April 2019 activity in the cytosolic fractions isolated from these cells was measured by a nonradioactive PKC assay. In comparison to the enzyme activity in cells on control substrata, the PKC activity in cells cultured on TN-C-containing substrata was reduced by about 50%.
To answer the question whether different cell types utilize the described mechanism in their interaction with the ECM, we examined the adhesion of cells expressing different levels of cell surface disialogangliosides to mixed FN fragment substrata. For this purpose, we chose skeletal muscle myoblasts from early postnatal mice and different neural cell lines (human glioma A 172 and U 87 MG and mouse N2A neuroblastoma cells) and compared their adhesion behavior ( Figure 6 ). As shown by indirect immunofluorescence studies of cultured cells, all five cell types used in the present study express the β 1 integrin receptor for FN (FNR; Figure 6A , a-c). These cell types differed, however, with respect to the expression of GD2 and/or GD3 at the cell surface. Whereas disialogangliosides were completely lacking on skeletal muscle myoblasts ( Figure 6A , f and k) and hardly detectable on U 87 MG cells, with the exception of a few large cells of flat morphology ( Figure 6A , h and m), L and A 172 cells were found to express different levels of GD2 ( Figure 6A , g and i) and/or GD3 ( Figure 6A , l and n). Highest levels of both disialogangliosides were detectable on N2A cells ( Figure 6A , j and o). On mixed substrata containing TN-C and the 75 kDa FN fragment, the degree of inhibition of cell adhesion correlated with the level of disialoganglioside expression by these cells ( Figure  6B ), i.e., highest for N2A cells (almost 100%), much lower for U 87 MG cells (about 30%) and not significant for the disialoganglioside-negative myoblasts (see Figure 6B inset ). By contrast, the inhibition of cell adhesion on TN-C + 33/66 kDa substrata did not correlate with the level of disialoganglioside expression ( Figure  6B ). For all disialoganglioside expressing cells, the inhibition of cell adhesion to TN-C + 75 kDa substrata was strongly reduced upon preincubation of these substrata with disialogangliosides (not shown). On mixed substrata containing TN-C and the intact FN molecule, the degree of inhibition of cell adhesion also correlated with the level of disialoganglioside expression by the different cell types (not shown), suggesting that integrin-mediated cell adhesion to FN represents the major adhesive mechanism utilized by these cells which overrides FN-dependent adhesion events mediated by other cellular receptors. As already mentioned for L cells, the adhesion of skeletal muscle myoblasts, U 87 MG, A 172, and N2A cells to mixed LN substrata was not affected by TN-C (not shown).
Discussion
In the present study, we provide evidence for a novel mechanism of inhibition of FN-mediated adhesion and neurite outgrowth by TN-C based on its interaction with cell surface disialogangliosides, which triggers a PKC-related signaling cascade affecting, directly or indirectly, the activity of an RGD-dependent integrin.
Several lines of evidence indicate that TN-C interferes with FN-mediated cell adhesion by binding to cell surface gangliosides. A variety of neural and nonneural cells expressing cell surface disialogangliosides or cells, whose cell surface glycoproteins were removed by extensive trypsinization, interact with TN-C and this interaction is selectively inhibited by polar glycolipid fractions, disialogangliosides and antibodies to gangliosides (3F8 and A2B5) or TN-C. As previously demonstrated for freshly trypsinized melanoma cells (Stallcup, 1988) , TGAtreated cells do not attach to FN. Such cells also do not attach to the 33/66 kDa heparin binding fragment of FN, which contains binding site for gangliosides (Matyas et al., 1986; Thompson et al., 1986) , nor do disialogangliosides interfere with L cell adhesion to BSA + 33/66 kDa substrata (Figure 3) , the latter being mediated by the interaction of cell surface heparan sulfate proteoglycans with the heparin binding sites of the FN molecule (Pesheva et al., 1994) . Our results thus further support the statement for the role of disialogangliosides rather as enhancers or modulators of integrin-mediated cell adhesion during the initial interactive step with the ECM than as a cell binding ligand for FN (Cheresh et al., 1986 (Cheresh et al., , 1987 . The ganglioside binding site on mouse TN-C is most likely localized in the region of the alternatively spliced FN III repeat TNfnD as defined by the interference of monoclonal antibody J1/tn2 with the glycosphingolipid-mediated interaction of cells with TN-C (Lochter et al., 1991; Husmann et al., 1992; Götz et al., 1996) . This antibody reacts also with the alternatively spliced variants of chicken, rat and human TN-C (Husmann et al., 1992; Götz et al., 1997; Scheffler et al., 1997) indicating that the ganglioside binding site is conserved throughout species.
Another finding of our study is that sulfatides, which have been shown to interact with TN-C by direct molecular binding assays (Crossin and Edelman, 1992) , do not interfere with disialoganglioside-mediated cell attachment to TN-C and exclude the possibility that the disialoganglioside-dependent inhibition is simply due to a sterical hindrance caused by glycolipid micelles. The binding site for sulfatide thus seems to be different from the ganglioside binding site. Since different disialogangliosides interfere with the interaction between L cells and TN-C, the two negatively charged sialic acid residues appear to be important for binding.
The interaction of TN-C with cell surface disialogangliosides mediates a selective inhibition of integrin-dependent cell adhesion and spreading on FN as TN-C interferes with cell adhesion to an RGD sequence-containing fragment or peptide of the FN molecule in a disialoganglioside-dependent manner. Another RGD-dependent integrin, the vitronectin receptor (α v β 3 ), also exists in a functional complex with disialogangliosides (Cheresh et al., 1986 (Cheresh et al., , 1987 and disialogangliosides are involved in cell adhesion to both FN and vitronectin (Stallcup, 1988) . The disialoganglioside-dependent inhibition of cell adhesion to the RGD sequence-containing peptide by TN-C thus suggests a more general mechanism of action in RGD-dependent cellular interactions with the ECM. Several integrins, including α v β 3 (Sriramarao et al., 1993; Yokosaki et al., 1996) , can serve as receptors for TN-C mediating diverse cellular responses, i.e., adhesive and anti-adhesive events, cell migration, and proliferation (for review, see Faissner et al., 1996) . The human α 8 β 1 integrin can function as a receptor for TN-C, FN, and vitronectin (Schnapp et al., 1995) . In all these studies, the cell binding sites on TN-C have been attributed to the C-terminal fibrinogen-like domain TNfbg (for α 2 β 1 integrin) or the third FN III repeat (TNfn3) containing the RGD sequence (for the integrins α v β 3 , α v β 6 , and α 9 β 1 , Joshi et al., 1993; Prieto et al., 1993; Sriramarao et al., 1993; Yokosaki et al., 1996) . Thus, the ganglioside binding side located in TNfnD is clearly distinct from these cell binding sides and obviously contributes to an additional diversity of integrin-mediated cellular responses to the ECM dependent on the cell surface levels of disialoganglioside expression. Binding of a recently identified non-integrin cellular receptor for TN-C on endothelial cells, annexin II, to the alternatively spliced TNfnA-D domain also appears to mediate several regulatory functions (i.e., mitogenic response, cell migration, and loss of focal adhesion) attributed to TN-C (Chung et al., 1996) demonstrating the existence of another, integrin/disialoganglioside-independent mechanism induced by the interaction of cells with the TNfnA-D domain. Notably, TN-C inhibits cell adhesion to the heparin binding fragment of FN in a ganglioside-independent manner. This mode of inhibition most likely results from the interaction of TN-C with sulfated proteoglycans and is not dependent on the amount of cell surface expressed disialogangliosides (see Figure 6 ). Interactions of TN-C with proteoglycans containing heparan or chondroitin sulfate glycosaminoglycan chains and their role in inhibition of cell adhesion or the formation of focal adhesion plaques have already been reported (Hoffman et al., 1988; Murphy-Ullrich et al., 1991; Salmivirta et al., 1991; Grumet et al., 1994) . The two, so far identified, heparin binding sites on TN-C reside within the fibrinogen-like domain and the fourth and/or fifth FN III repeat (TNfn4,5; Chiquet-Ehrismann et al., 1991; Aukhil et al., 1993; Fischer et al., 1995; Weber et al., 1995) and are thus different from the ganglioside binding site. Using recombinant fragments of the molecule, several groups have demonstrated the presence of both adhesive and anti-adhesive sites within the TN-C polypeptide (for review, see Chiquet-Ehrismann, 1995; Faissner et al., 1996) . Together with the finding of our present study that sialidase-treated cells retain their ability to attach to TN-C-containing substrata and preincubation of such substrata with disialogangliosides also results in a reduced/delayed cell detachment, an anti-adhesive, disialoganglioside-mediated, and adhesive mechanism, mediated by another cellular receptor(s) for TN-C, can be postulated. Prevention of TN-C-ganglioside interactions is not, however, sufficient to produce stable adhesion and spreading of cells on TN-C substrata arguing for the modulatory role of such interactions at initial stages of adhesion and the preponderance of another inhibitory mechanism(s) during later time points. Recent observations by Fischer and colleagues (1997) , who used TN-C deletion mutants expressed in vertebrate cells, in fact support the idea that the modulation of cell adhesion and neurite outgrowth by TN-C requires the concerted action of different molecular domains.
Neurite extension on FN requires the interaction of both integrins and cell surface proteoglycans with distinct binding sites on the molecule (Rogers et al., 1985; Bozyczko and Horwitz, 1986; Humphries et al., 1988) . Since (1) the inhibitory activity of TN-C is neutralized by disialogangliosides and (2) disialogangliosides do not affect cell attachment to heparin binding fragments of FN (Stallcup, 1988 ; the present study), inhibition of neurite outgrowth is most likely due to an interference with the RGD-dependent, integrin-mediated process. The role of cell surface gangliosides in inducing neurite outgrowth and supporting reinnervation has been demonstrated in a number of studies (reviewed by Hakomori, 1990; Thomas and Brewer, 1990) . In this respect, (1) the neurite outgrowth promoting activity of TN-C and TNfnD-containing protein fragments (Wehrle-Haller and Chiquet, 1993; Götz et al., 1996; Fischer et al., 1997) and (2) the involvement of the protein epitope recognized by antibody J1/tn2 in this process (Lochter et al., 1991; Götz et al., 1996 Götz et al., , 1997 and ganglioside-mediated interactions of cells with TN-C (the present study) suggest a ganglioside-dependent mechanism of TN-C action in neuritogenesis.
The disialoganglioside-mediated inhibition of cell adhesion and neurite outgrowth on FN by TN-C raises several important questions as to the mechanisms by which ligand binding to cell surface disialogangliosides can modulate the activity of β 1 integrins. The interaction of integrins with components of the ECM triggers cytoskeletal rearrangement at the inner membrane surface, a process involving tyrosine phosphorylation of focal adhesion proteins (reviewed by Hynes, 1992; Yamada and Miyamoto, 1995) . The inhibition of cell spreading and focal adhesion by TN-C, together with the findings that integrin β 1 subunits (Hayashi et al., 1990; Kornberg et al., 1991) , GD2 and GD3 (Cheresh et al., 1984) colocalize at focal adhesion sites, strongly suggest that the TN-C-disialoganglioside interaction at the cell surface leads to a sphingolipid turnover, which in turn affects PKC-related signaling cascades induced by integrins and leading to tyrosine phosphorylation of focal adhesion proteins (reviewed by Schwartz et al., 1995; Gumbiner, 1996) . Supporting this statement are our findings that substratum-bound antibody to GD2 ( Figure 5B ) and sphingosine, a potent inhibitor of PKC ( Figure 5C ), selectively inhibit focal adhesion to the RGD sequence-containing fragment of FN, and TN-C inhibits PKC activity in cells maintained on FN mixed substrata ( Figure 5D ). Notably, TN-C affects the phosphatidylinositol turnover in various cells in vitro (End et al., 1992) , further suggesting its implication in PKC-related signaling mechanisms. The latter are likely to involve inactivation of the focal adhesion kinase (FAK), which associates with focal adhesion proteins (reviewed by Schwartz et al., 1995; Gumbiner, 1996) , as current studies in our lab suggest that TN-C inhibits the tyrosine phosphorylation of FAK (P. Pesheva and R. Probstmeier, unpublished observations). Another intriguing possibility for an indirect action of TN-C on integrins is given by the observation that cell adhesion to the ECM may regulate the life cycle of integrins, i.e., block of substratum adhesion induces the internalization and degradation of β 1 integrins (Dalton et al., 1995) .
Taken together, our results imply the biological role of TN-C as a modulator of RGD-dependent cell-ECM interactions and neurite outgrowth during normal development, regeneration and oncogenesis, processes in which the functional involvement of TN-C has been suggested (Chiquet-Ehrismann, 1993; . In the developing CNS, TN-C glycoproteins are selectively expressed by glial lineages in areas with active neurohistogenesis where their coexpression with β 1 integrins and c, h, m), A 172 (d, i, n) , and N2A (e, j, o) cells were maintained for 3 days in culture and the expression of the β 1 integrin FN receptor (FNR, a-e) or disialogangliosides (f-o) was examined by indirect immunofluorescence. Cells were labeled extracellularly with polyclonal antibodies to the β 1 integrin (a-e) or monoclonal antibodies to GD2 (GD2, f-j) and GD3 (GD3, k-o). Scale bar, 50 µm. Note the lack of disialoganglioside expression by cultured myoblasts and, with the exception of few cells of flat morphology (arrowhead in h), the low amounts of GD2 and GD3 (small arrows in h, m) expressed by U 87 MG cells. (B) Inhibition of cell adhesion to 75 and 33/66 kDa substrata by substrate-bound TN-C. Myoblasts (myo), U 87 MG, A 172 and N2A cells (1 × 10 6 cells/ml culture medium) were plated onto mixed BSA or TN-C substrata containing the 75 kDa (+ 75 kD) or 33/66 kDa (+ 33 kD) FN fragment and maintained for 60 min in culture. For each cell type, the number of cells adherent to control BSA-containing substrata was set as 100%. Insert shows percent inhibition of cell adhesion to the 75 kDa FN fragment by TN-C extrapolated from the number of cells adhering to TN-C + 75 kDa substrata and related to the respective number of cells on control BSA + 75 kDa substrata. Values represent the means ± SD of two independent experiments performed in triplicates. Note that at comparable levels of β 1 integrin expression, the degree of inhibition of cell adhesion is proportional to the degree of disialoganglioside expression by these cells. disialogangliosides is likely to contribute to the molecular control of neural cell migration and the establishment of axonal projections by a disialoganglioside-driven mechanism. For instance, the transient expression of TN-C in the external granular layer of the early postnatal rodent cerebellum (Bartsch et al., 1992a) may allow the detachment of granule cell precursors, which transiently express β 1 integrin and GD3 (Hausmann and Sievers, 1985; Curtis et al., 1988; Stallcup, 1988; Stallcup et al., 1989) , from the FN-containing basal lamina and thereby favor their migration along the radial glial processes. Such molecular mechanism could also be operable in the control of (1) neuronal and glial precursor migration out of the ventricular zone of the neonatal brain (Stallcup et al., 1989; Sheppard et al., 1991; Götz et al., 1997) , (2) neuroepithelial cell migration out of the spinal neural tube (Bannerman et al., 1996) , (3) corneal cell migration in the developing retina (Kaplony et al., 1988; Sparrow and Barnstable, 1988) , or (4) the migration of GD3/β 1 integrin expressing O-2A progenitors (Curtis et al., 1988; Pesheva et al., 1988) in the developing optic nerve (Bartsch et al., 1992b) . Disialoganglioside-mediated interference with integrin-dependent adhesion of O-2A cells may also underlie the inhibition of their migration into the retina in the region of lamina cribrosa, demarcating the myelinated from the nonmyelinated part of the optic nerve (Fok-Seang et al., 1995; Kiernan et al., 1996) , where TN-C is expressed at this time period (Bartsch et al., 1994) . Similar mode of action could be attributed to TN-C in the regulation of axonal growth and plasticity, as disialogangliosides are enriched in the growth cone membrane and synaptosomes (Durrie et al., 1987; Sbaschnig-Agler et al., 1988) and antibody J1/tn2 interferes with the axonal outgrowth of thalamic and cortical neurons (Götz et al., 1997) . In the lesioned CNS, the upregulation of TN-C (Laywell et al., 1992; Scheffler et al., 1997) , disialogangliosides Bambrick et al., 1996) , FN and β 1 integrins (reviewed by Jones, 1996) often associates with reactive astrocytes and neurons (for disialogangliosides and integrins) and could thus contribute to remodeling of neuronal processes. Against the enthusiasm of many workers in the TN field, however, the TN-C gene knockout mouse showed no abnormal phenotype or any obvious defect in wound-healing (Saga et al., 1992) , suggesting that a compensatory mechanism and/or molecular/functional substitution must be present. Toward the latter possibility are our recent findings that TN-R, a member of the TN family expressed in the nervous system, also modulates RGD-dependent cell-ECM interactions by a ganglioside-mediated mechanism (Probstmeier et al., unpublished observations) . The functional relatedness of these structurally highly homologous glycoproteins thus raises the question of a functional substitution under conditions where one of these or possibly other related molecule(s) is lacking.
The high expression of TN-C by cells which have escaped from the normal cell cycle and growth control has been suggested to play a role in the formation, growth, and metastasis of tumors (Chiquet-Ehrismann, 1993; Giese et al., 1995; Zagzag et al., 1995) . Human neuroblastoma, glioma, and highly metastatic cells, such as melanoma and breast carcinoma cells, express considerable amounts of disialogangliosides (GD2, GD3, or their derivatives) involved in integrin-mediated adhesion of these cells to the ECM Cheresh et al., 1987; Burns et al., 1988; Marquina et al., 1996; von Holst et al., 1997) . The disialoganglioside-dependent mechanism described by us is of particular importance in the light of the observations that (1) the degree of TN-C-induced inhibition of cell adhesion, i.e., increased cell motility, is proportional to the cell surface levels of disialoganglioside expression (the present study) and (2) melanoma cells deficient in GD3 ganglioside expression exhibit slower growth rates and lower tumorigenicity (Nakano et al., 1996) implying a crucial role for TN-C or related ECM proteins in the control of cell-matrix interactions during tumor metastasis.
Materials and methods
Extracellular matrix proteins and fragments
TN-C, consisting of the 220 and 200 kDa isoforms, was immunoaffinity purified from early postnatal (3-day-old) mouse brain (Pesheva et al., 1994) . LN from EHS sarcoma and FN from human plasma were purchased from Sigma. The 75 kDa tryptic fragment containing the central cell binding domain of FN and the 33/66 kDa heparin binding FN fragment (kindly provided by Dr. L. Furcht and Dr. J. McCarthy, University of Minnesota) have been described previously (Pesheva et al., 1994) . The synthetic pentapeptide GRGDS containing the RGD cell binding site (Boehringer Mannheim) was conjugated to ovalbumin (Drake et al., 1992) .
Antibodies
Rat monoclonal antibodies J1/tn2 to J1/tn5 recognize different epitopes on TN-C (Husmann et al., 1992; Götz et al., 1996) . Mouse monoclonal antibody 3F8 (a kind gift of Dr. Nai-Kong V. Cheung, Memorial Sloan-Kettering Cancer Center, New York) was produced against human neuroblastoma cells and recognizes the disialoganglioside GD2 on different neuroblastoma and melanoma tumors Saito et al., 1985) . Mouse monoclonal antibody R24 recognizes the disialoganglioside GD3 on melanoma tumors and immature neural cells (Graus et al., 1984; Houghton et al., 1985 ; a kind gift of Dr. T. Pietsch, University of Bonn). Mouse monoclonal antibody A2B5 recognizes different gangliosides on immature glial cells and neurons (Fredman et al., 1984) . Rat monoclonal H28 (Hirn et al., 1981) and rabbit polyclonal antibodies to the neural cell adhesion molecule (NCAM; Probstmeier et al., 1990b) were also used. Polyclonal rabbit antibodies to TN-C, LN and FN were obtained as described (Pesheva et al., 1989) . Polyclonal rabbit antibodies directed against the FN receptor (FNR) derived from CHO cells recognize the 140 kDa heterodimeric (α 5 β 1 ) integrin complex in mouse and rat (Pesheva et al., 1994) . Affinity purified, cyanin 3-or fluorescein(DTAF)-conjugated goat anti-mouse, anti-rat, and anti-rabbit IgG were purchased from Jackson Immunoresearch Laboratories.
Glycolipids
Ganglioside mixture (type IV) containing mono-, di-, and trisialogangliosides; monosialoganglioside GM1; disialogangliosides GD1a, GD1b, GD2 (from bovine brain), and GD3 (from bovine milk); trisialoganglioside GT1b and sulfatides (from bovine brain) and D-sphingosine (from bovine brain cerebrosides) were purchased from Sigma. The fraction of polar glycolipids was isolated from adult mouse brain and rabbit RBC according to Hakomori and Siddiqui (1974) .
Cell cultures
Mouse L 929 fibroblast (L) and neuroblastoma (N2A) cells were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum (FCS, Boehringer Mannheim; Pesheva et al., 1994) . The human glioma cell lines U 87 MG and Downloaded from https://academic.oup.com/glycob/article-abstract/9/2/101/615469 by guest on 11 April 2019 A 172 (Giard et al., 1973 ; a kind gift of T. Pietsch and O. Wiestler, University of Bonn) were maintained in RPMI medium (Sigma) containing 10% FCS. Dorsal root ganglion neurons were prepared from neonatal NMRI mice and maintained in DMEM containing 10% FCS and 20 ng/ml nerve growth factor (Boehringer Mannheim; Pesheva et al., 1994) . Primary cultures of mouse myoblasts were prepared from early postnatal skeletal muscle and maintained in F 10 medium (Gibco) containing 20% FCS (Irintchev et al., 1997) .
Immunofluorescence
Cells were maintained for 2-3 days in vitro (see under "Cell cultures") on glass coverslips coated with poly-L-lysine (PLL, 0.1 mg/ml in H 2 O; Sigma). For semiquantitative analysis of indirect immunofluorescence, coverslips were treated with 4% paraformaldehyde (PA) in phosphate-buffered saline, pH 7.2 (PBS) for 30 min at room temperature, washed three times for 5 min with PBS containing 0.2% bovine serum albumin (BSA) and incubated for 15 min in Dulbecco's PBS (DPBS, Gibco) containing 10% horse serum (HS, Gibco; DPBS-HS). Coverslips were subsequently incubated for 30 min at room temperature with antibodies to cell surface glycolipids and proteins (diluted in DPBS-HS) and washed again. Antibody binding was detected by cyanin 3-or DTAF-conjugated anti-mouse, anti-rat or anti-rabbit IgG diluted in DPBS-HS (30 min at room temperature), and coverslips were embedded in glycerin:PBS (1:1, vol/vol). Immunofluorescence was evaluated by a fluorescence microscope (Axiophot, Zeiss) using standardized exposure times for the detection of gangliosides and β 1 integrins, respectively.
Treatment of cells with trypsin and glutaraldehyde
Glutaraldehyde-treated L (GA-L) cells were prepared essentially as described previously (Pesheva et al., 1994) . Briefly, single cell suspensions were washed with Hepes buffer (10 mM Hepes, 10 mM NaCl, 3 mM MgCl 2 , 2 mM CaCl 2 , pH 7.4) and treated with 1% glutaraldehyde (Serva) in Hepes buffer for 60 min on ice. Cells were then washed three times in 0.1 M glycine in Ca 2+ /Mg 2+ -containing Tris-buffered saline (3 mM MgCl 2 , 2 mM CaCl 2 , 20 mM Tris, 150 mM NaCl, pH 7.2) followed by two washing steps with Hepes buffer. Cells were stored at 4_C as a 5% suspension in Hepes buffer containing 0.02% sodium azide.
Extensively trypsinized, glutaraldehyde-treated L (TGA-L) cells were obtained by treating single cell suspensions of L 929 cells with trypsin (Boehringer Mannheim; 1% solution in Ca 2+ -and Mg 2+ -free Hank's balanced salt solution, CMF-HBSS) for 60 min at 37_C and subsequently washing in ice-cold PBS. Cells were further treated with 1% glutaraldehyde in PBS for 60 min at 4_C, washed three times with 0.2 M glycine in PBS and twice with PBS. Single cell suspensions (5% in PBS containing 0.02% sodium azide) were stored at 4_C. Rabbit RBC were prepared from 50 ml of fresh rabbit blood (Nowak et al., 1976 ) and further treated as described for TGA-L cells. For binding studies, single cell suspensions were used at a final density of 1 × 10 6 cells/ml as described under "Cell-substratum adhesion assays."
Sialidase treatment of cells L cells were treated with V. cholerae sialidase (Boehringer Mannheim) as described (Kojima and Hakomori, 1991) . Briefly, cells (1 × 10 6 ) were incubated without or with 0.1 U/ml sialidase in 1 ml PBS for 30 min at 37_C. The cells were then washed twice with PBS, resuspended in culture medium and immediately used for adhesion assays.
Analytical procedures
Protein determinations were carried out according to Bradford (1976) . Protein samples were separated by SDS-PAGE using 7% polyacrylamide slab gels (Laemmli, 1970) .
Cell-substratum adhesion assays
Cell-substratum adhesion assays were performed as described previously (Pesheva et al., 1994) . Briefly, BSA (fatty acid-free, from Sigma), LN, FN, or TN-C (all at 20 µg/ml in PBS) were coated as single substrata onto tissue culture plastic for 60 min at 37_C. For cell adhesion on mixed substrata, TN-C or purified mouse or rabbit IgG were mixed on ice with ECM molecules or fragments (1:1 (w/w) on a protein basis at a final protein concentration of 20 µg/ml) and coated as 2-3 µl droplets onto tissue culture plastic for 60 min at 37_C. Culture dishes were blocked with 1% BSA in PBS (60 min, 37_C) and subsequently washed with PBS. In perturbation experiments, coated substrata were incubated (60 min, 37_C) with antibodies (100 or 200 µg/ml in 1% BSA in PBS) or different glycolipid fractions (2-20 µg/ml in 1% BSA) and subsequently washed three times with PBS. Single cell suspensions obtained from monolayer cultures were plated into the substratum-coated dishes at densities of 0.5-1 × 10 6 cells/ml in DMEM containing 10% FCS or DMEM containing 0.1% BSA (incubation medium) containing or not antibodies to cell surface glycolipids (3F8 and A2B5) and incubated for various times at 37_C. Nonadherent cells were removed by gently washing the dishes with PBS and cell-substratum adhesion was evaluated microscopically.
Determination of the coating efficiency of ECM molecules in mixed substrata
The coating efficiencies of FN, 33/66 or 75 kDa fragment in a mixture with TN-C or IgG were determined by using 125 I-labeled TN-C, FN and FN fragments as previously described (Pesheva et al., 1994) . The coating efficiency of 125 I-labeled FN and 75 kDa fragment in a mixture with TN-C was slightly reduced (less than 20%) when compared to its mixture with BSA. The coating efficiency of 125 I-labeled 33/66 kDa fragment in a mixture with TN-C was reduced by about 30% corresponding to a coating concentration of about 6 µg/ml in BSA-containing substrata; at this coating concentration, a comparable number of L cells attached to the substrata, but their spreading was impaired. The coating efficiency of 125 I-labeled TN-C in a mixture with FN fragments was the same as in a mixture with BSA or LN. The amount of substratum-bound TN-C was not affected by preincubation of substrata with gangliosides. The coating efficiency of 125 I-labeled FN and FN fragments in a mixture with 3F8 IgG was the same as in a mixture with mouse nonimmune or rabbit polyclonal IgG to NCAM.
Determination of PKC activity in cultured cells
Mixed protein substrata were coated into tissue culture dishes (92 mm in diameter) and dishes were subsequently blocked as described (see under "Cell-substratum adhesion assays"). Single cell suspensions of L cells (5 × 10 6 cells/dish in DMEM containing 10% FCS) were plated into the substrate-coated dishes and after 60 min of culture, all cells were collected, washed once with cold PBS, and lysed in 0.2 ml of 20 mM Tris-HCl, pH 7.5, 5 mM EDTA, 10 mM EGTA, 50 mM β-mercaptoethanol, 1 mM PMSF, 10 mM benzamidine. Cell lysates were cleared by centrifugation (100,000 × g for 30 min at 4_C) and PKC activity in the cytosolic fraction was determined by using the nonradioactive protein kinase assay kit (Calbiochem) according to the manufacturer's instructions. The values for PKC activity in each cell lysate were plotted onto a standard curve prepared from serial dilutions of PKC purified from rat brain (Calbiochem) assayed in parallel.
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